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• Budget: about US$80 million
• Senior scientists from 39 countries
• One third of ILRI staff are women
• Main campuses in Kenya and Ethiopia, 
and offices in 14 other countries 
around the world
Main campuses: Nairobi, 
Kenya and Addis Ababa, 
Ethiopia































































































































































World Europe South-Eastern Asia Southern Asia sub-Saharan Africa
Courtesy Mats Lannerstad. Grace et al. (forthcoming)
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Source: Van Boeckel et al. (2015)
Global antimicrobial consumption in livestock  
(mg per 10km pixel)
Antimicrobial use in livestock
• Total consumption in the livestock 
sector in 2010 estimated at 63,151 
tons
• Global antimicrobial consumption 
will rise by 67% by 2030
• It will nearly double in BRICS 
nations
• Animal disease is a key constraint in LMIC:
Remove it and animal productivity increases greatly
Animal disease is a key constraint
AM Resistance and livestock in LMIC
Different systems in LMIC – can’t 
use “one size fits all” approach
Need to address the “too much” 
and the “too little”
Next slides:
• AM usage in LMIC
• Contribution of AM usage in 
livestock to AMR
• How to tackle it? 
Reality check 
• Salbutamol – ‘growth promoter’ in 
pigs
• Clearly illegal in Vietnam
• High concern of authorities and 
consumers
• Easy to test for
In 2015, 6000 kg salbutamol imported and sold:
10 kg had a legitimate medical use (Van Duan and Huong 2016) 
11% of packaged feed and 4% of pork pooled samples were positive 




• 45 antibiotics from 10 classes
• 100% industrial farmers treat 
themselves; 60% of household 
farmers
Cuong et al. (2015)
AM usage - smallholder farming
No official records - less usage than intensive units
Some of the problems commonly found across LMIC:
• Misuse: Poor diagnostic capacity and wrong treatment (no vets) 
• Under-dosage: poor access to drugs
• Under-dosage: poor administration of drugs
• Most AM obtained from informal markets 
14
Africa: dozens of vets, tens of millions livestock
Reality check
AM use in LMIC and AMR
AM usage in animals:
• likely to lead to resistance in animal 
pathogens 
• Likely to lead to increase circulation of 
resistant strains of zoonotic pathogens 
(especially foodborne pathogens)
• Possibly, but rarely demonstrated, could 
lead to resistance of human pathogens 
(not zoonotic). Only demonstrated in 
few cases.
• For human pathogens – it is unlikely the 
primary source of resistance comes 
from AM use in animals.
Kampala pork butcheries: Salmonella
Heilmann and Ndoboli (2015)
All isolates were confirmed Salmonella at 















































Source: Ndoboli et al. (forthcoming)
>85% resistance
Addressing AMR in LMIC
• Reducing use:
– Must be a targeted approach
– Requires improving monitoring and diagnostic capacities in 
LMIC
– Regulation and enforcement – unlikely to work in many 
settings
• Reducing transmission:
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better lives through livestock
ilri.org
